drugset / Trial / NCT02923557

Prophylactic Intravesical Chemotherapy to Prevent Bladder Recurrence After Nephroureterectomy for Primary Upper Tract Urothelial Carcinoma Patients

NCT02923557

Phase 2 Unknown 200 enrolled Peking University First Hospital
RandomizedSingle-groupSingle-blindPrevention

Summary

This clinical trial is designed to evaluate the efficacy of single immediate intravesical chemotherapy instillation in the prevention of bladder recurrence after nephroureterectomy for primary upper tract urothelial carcinoma (UTUC) patients.

Timeline

Start
2016-11
Primary completion
2021-11
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Pirarubicin Small molecule 40 mg Other